Award notice Supplies

Pomalidomide

Notice published in French. The AI analysis summarises it for you in your language.

Official notice and documents

Public buyer: Cliniques universitaires Saint Luc
Woluwe-Saint-Lambert
Place of performance: 1200 Woluwe-Saint-Lambert, Brussels-Capital
not published: buyer's address
Amount awarded: €268,870 excl. VAT
Planned end of contract: 12 May 2030
likely re-tender around November 2029
Bids received: 3
Form: Framework agreement
Multi-year contract: the buyer places orders as needs arise.
Procedure: Open procedure
Any company may submit a bid.
Publication: 19 May 2026
Notice language: French

AI analysis: go for it or not?

Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.

Create my free account

Unlimited analyses during the 14-day Pro trial, no card needed.

Description

Le marché concerne les fournitures de la spécialité pharmaceutique contenant le principe actif « Pomalidomide ».

Awarded to

EG BCE/KBO 0419.806.694

CPV codes

European codes that classify what the contract is about. They are how we find the tenders for your trade.

33652000

Winning prices for comparable contracts

A quarter below: €290,000
Median: €403,000
A quarter above: €1,351,075

Amounts awarded (excl. VAT) over the last 3 years for 5 contracts in the same CPV group (3365…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.

Similar contracts already awarded

Contract	Winner	Amount
Immunoglobuline humaine normale pour administration intraveineuse Cliniques universitaires Saint Luc · 22 October 2026	CSL BEHRING	€16,277,080
Rituximab Cliniques universitaires Saint Luc · 19 August 2026	Celltrion Healthcare Netherlands B.V.	€628,800
Infliximab Cliniques universitaires Saint Luc · 19 August 2026	Celltrion Healthcare Netherlands B.V.	€2,492,000
Bévacizumab Cliniques universitaires Saint Luc · 7 July 2026	Celltrion Healthcare Netherlands B.V.	€503,440
Antimycotica AZ Delta vzw · 21 October 2026	Arega Pharma NV Sandoz NV Fresenius Kabi NV Pfizer NV	€300,945

Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 342468-2026.